Annual Retained Earnings
-$11.30 M
-$529.00 K-4.91%
December 31, 2023
Summary
- As of February 7, 2025, CDT annual retained earnings is -$11.30 million, with the most recent change of -$529.00 thousand (-4.91%) on December 31, 2023.
- During the last 3 years, CDT annual retained earnings has fallen by -$5.42 million (-92.26%).
- CDT annual retained earnings is now -92.26% below its all-time high of -$5.88 million, reached on December 31, 2021.
Performance
CDT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$26.70 M
-$6.46 M-31.93%
September 29, 2024
Summary
- As of February 7, 2025, CDT quarterly retained earnings is -$26.70 million, with the most recent change of -$6.46 million (-31.93%) on September 29, 2024.
- Over the past year, CDT quarterly retained earnings has dropped by -$13.62 million (-104.12%).
- CDT quarterly retained earnings is now -147.86% below its all-time high of -$10.77 million, reached on December 31, 2022.
Performance
CDT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CDT Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.9% | -104.1% |
| 3 y3 years | -92.3% | -104.1% |
| 5 y5 years | -92.3% | -104.1% |
CDT Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.3% | at low | -147.9% | at low |
| 5 y | 5-year | -92.3% | at low | -147.9% | at low |
| alltime | all time | -92.3% | at low | -147.9% | at low |
Conduit Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$26.70 M(+31.9%) |
| Jun 2024 | - | -$20.23 M(+36.2%) |
| Mar 2024 | - | -$14.85 M(+31.4%) |
| Dec 2023 | -$11.30 M | -$11.30 M(-13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$13.08 M(-15.3%) |
| Jun 2023 | - | -$15.44 M(+19.4%) |
| Mar 2023 | - | -$12.93 M(+20.0%) |
| Dec 2022 | -$10.77 M(+83.3%) | -$10.77 M |
| Dec 2021 | -$5.88 M | - |
FAQ
- What is Conduit Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals annual retained earnings year-on-year change?
- What is Conduit Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals quarterly retained earnings year-on-year change?
What is Conduit Pharmaceuticals annual retained earnings?
The current annual retained earnings of CDT is -$11.30 M
What is the all time high annual retained earnings for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high annual retained earnings is -$5.88 M
What is Conduit Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, CDT annual retained earnings has changed by -$529.00 K (-4.91%)
What is Conduit Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CDT is -$26.70 M
What is the all time high quarterly retained earnings for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high quarterly retained earnings is -$10.77 M
What is Conduit Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, CDT quarterly retained earnings has changed by -$13.62 M (-104.12%)